B Cell Maturation Antigen（BMCA）-Targeted CAR-T for Refractory/Relapsed Multiple Myeloma
type: MedicalStudy
description: B Cell Maturation Antigen（BMCA）-Targeted CAR-T for Refractory/Relapsed Multiple Myeloma
status: UNKNOWN
study design: INTERVENTIONAL
phase: PHASE2
start date: 2019-07-31
end date: 2022-12-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT03931421
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: First Affiliated Hospital of Zhejiang University
study subject: Multiple Myeloma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: UNKNOWN
keywords: Multiple Myeloma

AI Analytics
type: Organization